본문으로 건너뛰기
← 뒤로

Immune system, inflammatory response, and regulated cell death in breast cancer research (Review).

Oncology reports 2026 Vol.55(1)

Li G, Jin B, Zhou J, Fang S, Fan Z

📝 환자 설명용 한 줄

Breast cancer (BC) ranks among the most prevalent malignant tumors in female patients.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Li G, Jin B, et al. (2026). Immune system, inflammatory response, and regulated cell death in breast cancer research (Review).. Oncology reports, 55(1). https://doi.org/10.3892/or.2025.9016
MLA Li G, et al.. "Immune system, inflammatory response, and regulated cell death in breast cancer research (Review).." Oncology reports, vol. 55, no. 1, 2026.
PMID 41201017

Abstract

Breast cancer (BC) ranks among the most prevalent malignant tumors in female patients. It represents a longstanding challenge to medical professionals in terms of diagnosis and treatment. Exploring BC pathogenesis offers insight into its complexity and facilitates the exploration of more effective treatment strategies. The present review aimed to describe the involvement of the immune system, inflammatory response and regulated cell death in BC development, offering avenues for novel therapeutic strategies against BC. Identifying novel treatment methods is key for enhancing the prognosis of patients with BC.

MeSH Terms

Humans; Breast Neoplasms; Female; Inflammation; Regulated Cell Death; Immune System; Prognosis; Tumor Microenvironment

같은 제1저자의 인용 많은 논문 (5)